The pandemic years caused upheaval for people all around the U.S and the residents of Washington were no exception. The coronavirus disrupted everyday life, leading to widespread anxiety, depression and other mental health issues. Increases drug addiction, alcoholism and daily smoking also challenged the population's well-being.
According to the Washington State Department of Health, over 26% of adults have severe anxiety and 20% with clinical depression in 2020. Meanwhile, drug addiction, alcoholism and tobacco use affected 3%, 7%, and 15% of adults, respectively. A survey conducted by the Centers for Disease Control and Prevention (CDC) reported a rise in anxiety and depression to over 40% of Washington residents after the pandemic.
These figures are particularly concerning when one considers Washington's population increased significantly in recent years climbing to 8 million people. Research shows microdosing Washington psilocybin mushrooms is the best treatment for these conditions. Psilocybin is a naturally occurring compound found in certain species of mushrooms and when consumed have profound effects on the brain.
The Journal of Psychopharmacology found that microdosing mushrooms reduces symptoms of anxiety and depression in cancer patients. Another study found microdosing psilocybin helps people overcome addiction to nicotine and alcohol. The therapeutic benefits of magic mushrooms in Washington result from psilocybin's ability to activate certain receptors in the brain that involve in mood regulation and emotional processing. Microdosing mushrooms allow individuals to experience holistic benefits without intense psychedelic effects associated with higher doses of psilocybin. Psilocybin has no potential for addiction and is not associated with any harmful side effects as many prescription medications.
In Washington, there are an estimated 500,000 veterans, many of whom suffer from post-traumatic stress disorder (PTSD). PTSD is a mental health condition that affects individuals who have experienced or witnessed a traumatic event in combat. A study conducted at Washington State University found that a single dose of psilocybin reduces symptoms of PTSD in veterans by up to 80%. In addition, the University of Washington is doing clinical studies on the use of psilocybin to treat drug addiction.
While prescription medications like selective serotonin reuptake inhibitors (SSRIs) are commonly used to treat anxiety, depression and PTSD, they come with a host of side effects. SSRIs cause nausea, insomnia, sexual dysfunction and increase the risk of suicidal thoughts in some individuals. This potential risk is particularly concerning given the high prevalence of suicide in Washington. In 2019, there were over 1,300 suicide deaths in the state.
In contrast, psilocybin is well-tolerated by most individuals and is not associated with any risk of suicide. Unlike prescription medications, microdosing Washington magic mushrooms does not require daily use, making it a more convenient and cost-effective treatment. The lockdown measures made it challenging for individuals to access traditional mental health care services, making alternative treatments like microdosing Washington mushrooms the best option.
Research into the benefits of microdosing magic mushrooms for mental health conditions is ongoing and Washington is at the forefront. In 2020, the Washington State Senate passed a bill legalizing therapeutic use of psilocybin mushrooms. The bill aims to provide safe and legal access to microdosing Washington mushrooms for people struggling with mental health conditions. Microdosing Washington mushrooms is the most effective holistic treatment with easy accessibility.